Ifabotuzumab CAS No.2147698-66-4
Ifabotuzumab CAS No.2147698-66-4
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1546 | 5mg | 720.00 | + Add to cart |
|
| R-R-1546 | 10mg | 1150.00 | + Add to cart |
|
|
|
||||
Product description
Ifabotuzumab (KB004)/CAS No.2147698-66-4 is an IgG1κ antibody targeting EphA3 (KD=610 pM). Ifabotuzumab induces tumor cell apoptosis, activates Antibody-dependent cell mediated cytotoxicity (ADCC), and damages tumor vasculature. Ifabotuzumab reduces human idiopathic pulmonary fibrosis (IPF) CCR10+ cells and improves pulmonary fibrosis.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| CAS | 2147698-66-4 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Ifabotuzumab CAS No.2147698-66-4
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


